AstraZeneca Malaysia demonstrated a strong commitment to combating lung disease on World Health Day 2024. The company unveiled a comprehensive set of initiatives addressing early detection of lung cancer and chronic obstructive pulmonary disease (COPD), alongside broader efforts focused on lung health, disease prevention, and community wellness.
Key Programme Developments
MyLUNG Health Launch: AstraZeneca expands its commitment to lung health with the launch of the MyLUNG Health programme, prioritising early detection of lung cancer and COPD.
Strategic Partnerships: AstraZeneca Malaysia formalised strategic alliances with the following organisations through Memoranda of Understanding, aiming to bolster lung health advocacy, screening access, and policy influence:
- Twin Towers Medical Centre
- Lung Cancer Network Malaysia (LCNM)
- National Cancer Society Malaysia (NCSM)
- Qure.ai
- MedTweetMy
- Qualitas Health Malaysia
Corporate Community Screening Programme: AstraZeneca organised a two-day health screening event, emphasising accessible healthcare. Key offerings included:
- AI-assisted chest X-rays with rapid results
- Spirometry assessments for lung function
- Blood screenings and donation opportunities
- Pap smears
- Health insurance/financial literacy consultations
- Fitness activities
The Power of Collaboration: AstraZeneca emphasises the critical role of collaborations for success in healthcare initiatives. Robust partnerships with medical providers, patient groups, technology innovators, and community organisations drive their mission.
Improving health outcomes together AstraZeneca’s multifaceted approach to lung health and community wellbeing highlights the potential for positive impact in the healthcare sector. By fostering collaborative initiatives and emphasising the importance of preventative care, their aim is to collectively improve health outcomes within our communities.
